LB Pharmaceuticals separates from Dr. Anna Eramo with severance through June 2027
LB Pharmaceuticals Inc. terminated employment of Dr. Anna Eramo effective June 15, 2026, with severance payments through September 2026 and potential extension through June 2027 pending consulting agreement compliance. The executive separation includes base salary continuation and a prorated bonus payment, representing a standard leadership transition.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed